News

Published on 1 May 2024 on Zacks via Yahoo Finance

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick


Article preview image

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Is This 1 Momentum Stock a Screaming Buy Right Now?

NASDAQ.BIIB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen

Insights into the First Quarter Moves of Auxier Asset Management Jeff Auxier (Trades, Portfolio),...

GuruFocus.com via Yahoo Finance 8 May 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript May 7, 2024 AbCellera Bio...

Insider Monkey via Yahoo Finance 8 May 2024

Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss

Ionis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which wa...

Zacks via Yahoo Finance 8 May 2024

Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus

Denali Therapeutics DNLI incurred a first-quarter 2024 loss of 68 cents per share, wider than the...

Zacks via Yahoo Finance 8 May 2024

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing...

Zacks via Yahoo Finance 8 May 2024

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

For Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured...

Zacks via Yahoo Finance 3 May 2024

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks via Yahoo Finance 1 May 2024

This midcap stock is up 11% after smashing earnings estimates this morning By Investing.com

This midcap stock is up 11% after smashing earnings estimates this morning

Investing.com 30 Apr 2024

At Biogen, CEO Viehbacher got less total pay than many executives last year - Boston Business...

When Christopher Viehbacher became CEO of Biogen Inc. in late 2022, he landed $30.5 million in to...

The Business Journals 29 Apr 2024

Decoding Biogen Inc (BIIB): A Strategic SWOT Insight

Biogen Inc's robust product portfolio and pipeline offer a competitive edge in the neurology and ...

GuruFocus.com via Yahoo Finance 26 Apr 2024